CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 6 enrolled
Drug / intervention
dalcetrapibdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01476267
NCT01476267Phase 1Completed
CompareCT.gov

An Open Label, Single Centre Study to Investigate the Metabolic Profile of Dalcetrapib After a Single Oral Dose in Healthy Male Subjects

Hoffmann-La Roche·interventional·Posted Nov 22, 2011·Updated Dec 17, 2019

In Brief

A Phase 1 clinical trial evaluating dalcetrapib for Healthy Volunteer. Completed, enrolled 6 participants across 1 site.

Detailed Summary

This single center, open-label, non-randomized, one-treatment, one-period study will evaluate the metabolic profile and the safety of a single oral radiolabeled dose of dalcetrapib in male healthy volunteers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteer
CountriesNetherlands
Collaborators--

Timeline

Phase 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedNov 22, 2011
Enrollment StartOct 1, 2011
Primary CompletionNov 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 14.6 years ago

Interventions

dalcetrapibdrug

Single oral radiolabeled dose